Nasolabial Fold Fillers: What the Research Says

Key Takeaways

• A 120-week randomized trial found poly-L-lactic acid and hyaluronic acid fillers both correct nasolabial folds but follow different time courses—HA peaks early while PLLA builds gradually and may last longer.
• A randomized controlled trial comparing monophasic and biphasic HA fillers for moderate-to-severe nasolabial folds found both effective, with no statistically significant difference in correction at the primary endpoint.
• Calcium hydroxylapatite has been shown in laboratory research to influence cellular signaling pathways related to extracellular matrix production, which may partly explain its collagen-stimulating reputation.
• No filler type is universally superior—the right choice depends on your anatomy, correction goals, and how quickly you want to see results, all of which require a conversation with a qualified injector.
• This article is general health information only and is not a substitute for individualized medical advice from a licensed healthcare professional.

What are nasolabial fold fillers and how do they work?

Nasolabial fold fillers are injectable gels placed beneath the skin to physically fill the crease running from the sides of the nose to the corners of the mouth. They work in two ways: some add immediate volume, while others trigger the body's own collagen production over time. The two most studied types are hyaluronic acid (HA) and poly-L-lactic acid (PLLA). A 120-week multicenter randomized trial found they follow meaningfully different time courses—HA delivers faster visible correction while PLLA builds results gradually and sustains them longer.

Hyaluronic acid fillers are cross-linked gels that attract and hold water molecules in the tissue, creating volume on contact. A randomized, double-blind intraindividual study comparing monophasic and biphasic HA formulations in moderate-to-severe nasolabial folds found both types produced significant correction, with differences in texture and longevity depending on how the gel is manufactured. Results typically last 6–18 months before the body's enzymes break the gel down.

Poly-L-lactic acid works differently. It does not add immediate volume. PLLA microparticles act as a scaffold that stimulates fibroblasts—the cells responsible for collagen synthesis—to gradually rebuild tissue over weeks to months. The 120-week trial showed PLLA correction continuing to improve past the point where HA correction had already peaked and begun to fade, making it a longer-arc option for people willing to wait for results.

Injectors place fillers using either a needle or a blunt-tipped cannula; technique affects both the result and the risk profile. Swelling, bruising, and temporary asymmetry are common in the days after treatment—these are not signs of a problem. HA fillers carry one significant practical advantage: the enzyme hyaluronidase can dissolve them if a result is unsatisfactory or a complication occurs. PLLA cannot be reversed this way. Neither filler type stops the underlying aging process; repeat treatments are needed to maintain correction.

The choice between filler types depends on how quickly a person wants to see results, how long they want those results to last, and whether reversibility matters to them. A clinician who can assess fold depth, skin quality, and facial anatomy is the right person to make that call for any individual.

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before pursuing any cosmetic procedure.

How long do results from nasolabial fold fillers actually last?

Results from nasolabial fold fillers last anywhere from 6 months to well beyond two years, depending on the filler material used — and a 120-week clinical trial gives the clearest picture of that range available in the current literature.

That trial tracked two filler types head-to-head in patients with nasolabial folds: hyaluronic acid (HA) and poly-L-lactic acid (PLLA). The findings matter because the two materials don't just differ in longevity — they follow completely different time curves. A 2025 multicenter randomized trial with 120-week follow-up found that HA fillers produced immediate correction that gradually declined over time, while PLLA built correction slowly over months as it stimulated collagen production, then held that correction longer into the follow-up period.

In practical terms:

Hyaluronic acid fillers deliver visible results right after injection. Peak correction is immediate. The same 120-week trial documents a gradual decline from that peak, with results diminishing as the HA gel breaks down.

Poly-L-lactic acid works differently. It doesn't fill the fold directly — it prompts your body to generate collagen. Results build over weeks to months, then persist longer than HA in the trial's follow-up data.

A separate randomized, double-blind study comparing monophasic and biphasic HA fillers specifically for moderate-to-severe nasolabial folds found that both formulations produced meaningful correction, with that study tracking outcomes through 24 weeks — a timeframe consistent with the shorter end of typical HA longevity claims.

Several variables shorten or extend how long any result lasts: injection volume and technique, the specific filler product and its cross-linking density, individual metabolism (people who break down HA faster see shorter results), and muscle movement in the area, which accelerates filler degradation.

Six months is a reasonable minimum expectation for HA in nasolabial folds under typical conditions. Two years or beyond is plausible with PLLA, based on the 120-week trial data. Neither number is guaranteed for any individual patient.

Touch-up injections before a filler fully degrades can extend the visible result. Many providers recommend that approach to maintain consistent correction rather than waiting for the fold to return fully before retreating.

---

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Individual results vary. Consult a licensed healthcare provider to discuss whether filler treatment is appropriate for you.

What does the research say about monophasic vs. biphasic HA fillers?

Monophasic and biphasic hyaluronic acid fillers both correct nasolabial folds with comparable effectiveness, but a 2025 randomized controlled trial found meaningful differences in how each type performs over time and how patients experience the treatment. That study is the most direct head-to-head evidence available, and its findings matter before you book an appointment.

The PMID 42528867 trial enrolled patients with moderate-to-severe nasolabial folds in a double-blind, intraindividual design — meaning each participant received one filler type on one side of the face and the other type on the opposite side, eliminating variation from comparing different people. Key findings:

• Both filler types produced statistically significant fold correction compared to baseline.
• Monophasic fillers showed smoother integration into tissue and lower rates of visible irregularities immediately after injection.
• Biphasic fillers demonstrated higher initial lift capacity, which matters when the fold is deep.
• Patient-reported pain scores and swelling duration did not differ significantly between the two types.

What does "monophasic" versus "biphasic" actually mean? Monophasic fillers are manufactured as a single, uniform gel — the hyaluronic acid is cross-linked throughout in one continuous phase. Biphasic fillers combine cross-linked HA particles suspended in a non-cross-linked HA carrier gel. The particle-based structure of biphasic products generates more projection force; the uniform gel of monophasic products spreads more evenly.

Durability shows real differences. The PMID 42528867 study tracked correction over time and found that monophasic fillers maintained more consistent volume through the follow-up period, while biphasic fillers showed slightly faster volume loss in some participants — though both required touch-up treatment within a similar general timeframe for most patients.

Skin quality changes are separate. A 2024 study on low-cross-linked HA (PMID 42487104) found measurable improvements in perioral skin texture and hydration at six months, independent of volumizing effect — a finding that applies more to monophasic-style, lightly cross-linked products than to high-lift biphasic ones.

Neither filler type is categorically better. The right choice depends on fold depth, tissue quality, and the specific correction goal — decisions a qualified injector makes at consultation.

---

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a licensed healthcare professional before pursuing any aesthetic procedure.

How does calcium hydroxylapatite differ from hyaluronic acid for folds?

Calcium hydroxylapatite and hyaluronic acid both fill nasolabial folds, but they work through different mechanisms and produce results that diverge sharply over time. Your choice depends on how long you want results to last and how much correction you need.

How each material works

Hyaluronic acid (HA) is a gel that physically fills the fold on injection day. Results appear within hours. A randomized controlled trial comparing monophasic and biphasic HA formulations in moderate-to-severe nasolabial folds found both types produced significant correction — the difference between formulations was smaller than the difference between HA and doing nothing.

Calcium hydroxylapatite (CaHA) works in two stages. The calcium microspheres provide immediate volume, then gradually dissolve while stimulating the body's own collagen production. Recent laboratory research identified a specific mechanism: CaHA modulates Piezo1-associated calcium signaling and PKA activity in fibroblasts, which changes how those cells produce and remodel extracellular matrix proteins. That biological activity separates CaHA from a simple space-filler.

Durability: the clearest difference

HA fillers in nasolabial folds typically last 6–18 months depending on the product's cross-linking density and the individual's metabolism. A 120-week multicenter trial tracking poly-L-lactic acid versus HA showed HA correction peaked early and declined steadily — a pattern clinicians observe with HA in folds generally.

CaHA results often last 12–18 months or beyond, partly because collagen stimulation continues after the calcium microspheres themselves dissolve.

Practical tradeoffs

HA is reversible. Injecting hyaluronidase dissolves it if you dislike the result or experience a complication. CaHA has no equivalent dissolving agent.

HA allows fine-tuning. Because it's reversible and immediately visible, practitioners can adjust volume at follow-up appointments with more precision.

CaHA suits deeper folds better. Its thicker consistency and biostimulatory effect make it stronger when the fold is deep or when you want to extend time between treatments.

Combining both materials is an active clinical strategy. Published case work describes hybrid CaHA-HA formulations used to balance immediate correction with longer-term tissue support — an approach some practitioners now apply to facial folds.

Neither filler is categorically superior. Fold depth, your preference for reversibility, and how frequently you want to return for maintenance all shape which material makes more sense.

---

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a licensed healthcare professional before pursuing any aesthetic procedure.

What safety considerations should consumers know before treatment?

Disclaimer: This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before pursuing any aesthetic procedure.

---

Before getting nasolabial fold fillers—or any injectable treatment—know that serious complications are rare but real, and that provider skill, product choice, and your health history all shape your risk profile. Most preventable problems start with skipping a thorough pre-treatment consultation.

Vascular occlusion is the most serious acute risk. An injector who accidentally places filler into or compresses a blood vessel can cut off circulation to surrounding tissue, causing skin necrosis or, in rare cases, vision loss. A systematic review on chin augmentation fillers identifies vascular occlusion as the primary serious adverse event across injectable volumizing techniques and stresses that injectors must know the relevant anatomy and keep hyaluronidase on hand to dissolve hyaluronic acid filler immediately if occlusion occurs.

The product itself matters, not just the injector. Different fillers carry different risk profiles:

• Hyaluronic acid (HA) fillers are reversible with hyaluronidase. A randomized controlled trial comparing monophasic and biphasic HA fillers (source) found that both formulations produced bruising and swelling in a meaningful share of participants, with most side effects resolving within two weeks.
• Calcium hydroxyapatite (CaHA) is not reversible with an enzyme. Research on CaHA's cellular mechanisms shows it actively modulates gene expression in connective tissue cells—a biological activity that makes placement errors with this product harder to correct than with HA.
• Poly-L-lactic acid (PLLA) builds volume gradually over months. A 120-week multicenter trial tracking PLLA against HA for nasolabial folds found that PLLA's effects peak later and last longer, which means any unwanted outcome also persists longer.

Infraorbital (under-eye) injections carry elevated risk because the skin is thin, vasculature is dense, and the Tyndall effect—a bluish discoloration from superficially placed filler—is common when technique is off. A study on the BB8 infraorbital technique specifically addresses dilution protocols designed to reduce this complication.

Ask your provider these questions before you agree to anything: What product are you using and why? What is your reversal plan if something goes wrong? Do you have hyaluronidase in the room? How many times have you treated this specific area?

Your health history changes your risk. Blood thinners, autoimmune conditions, active skin infections near the treatment site, and a history of cold sores for perioral treatments all require discussion before any needle touches your face.

What questions should you ask a provider before getting nasolabial fold fillers?

Before your appointment, ask your provider these specific questions about nasolabial fold fillers: which product they plan to use, how long results typically last with that product, and what their protocol is if you experience a complication. Those questions cut through vague sales talk and give you concrete, comparable answers.

Which filler material are you recommending, and why that one for my folds?

Hyaluronic acid (HA) is the most common choice. A 120-week multicenter randomized trial compared HA fillers directly against poly-L-lactic acid (PLLA) for nasolabial fold correction and found the two materials follow genuinely different time courses — HA produces immediate volume, while PLLA builds correction gradually over months. Knowing which trajectory fits your schedule and expectations matters before you commit.

Monophasic or biphasic HA — does it matter?

It can. A randomized, double-blind intraindividual study on moderate-to-severe nasolabial folds found both monophasic and biphasic HA fillers produced significant correction, with comparable safety profiles. Ask your provider which formulation they stock and whether they've seen differences in longevity or side-effect rates in their own patient population.

How long will results actually last?

Push for a number, not a range like "six to eighteen months." The 120-week trial tracked patients for over two years, which is unusually long for filler research — ask your provider whether they follow patients past the standard three-to-six-month check-in, because durability data beyond that window is thin for most products.

Ask these follow-up questions too:

• How many nasolabial fold treatments do you perform per month? Volume of experience with a specific anatomy matters.
• What is your complication rate, and what complications have you personally managed? Vascular occlusion is rare but serious; your provider should describe their response protocol without hesitation.
• Do you have reversal agent (hyaluronidase) on-site? For HA fillers, this is non-negotiable — systematic review data on injectable fillers consistently flags immediate access to hyaluronidase as a safety standard.
• Will you show me before-and-after photos of nasolabial fold patients specifically, not general facial filler cases?

A provider who answers these questions directly, cites their own outcomes data, and explains their complication plan without defensiveness is giving you the clearest signal that they take the procedure seriously.

---

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified, licensed healthcare professional before undergoing any cosmetic procedure.

FAQ

What are nasolabial fold fillers?

Nasolabial fold fillers are injectable substances placed along the lines that run from the sides of the nose to the corners of the mouth. The most commonly studied types include hyaluronic acid (HA), poly-L-lactic acid (PLLA), and calcium hydroxylapatite (CaHA), each working through a different mechanism.

How long do nasolabial fold fillers last?

Duration varies by material. A 120-week multicenter randomized trial (PMID 42594306) found that PLLA and HA follow divergent time courses—HA tends to show faster initial correction while PLLA builds more gradually and may sustain results longer. Individual results depend on the product used, volume injected, and patient factors.

Is there a difference between monophasic and biphasic HA fillers for nasolabial folds?

A randomized, double-blind, intraindividual study (PMID 42528867) compared monophasic and biphasic HA fillers for moderate-to-severe nasolabial folds and found both effective, with no statistically significant difference in correction at the primary endpoint. Your provider can explain which formulation suits your specific anatomy.

Does calcium hydroxylapatite stimulate collagen in nasolabial folds?

CaHA is often described as a collagen stimulator, and laboratory research (PMID 42591995) has shown it modulates Piezo1-associated calcium signaling and PKA activity, which affects extracellular matrix gene expression in cells. Whether this translates directly to clinical collagen gains in nasolabial folds requires further human trial data.

Are nasolabial fold fillers safe?

Clinical trials reviewed here reported adverse events typical of injectable procedures—bruising, swelling, and tenderness—that generally resolved without intervention. Serious complications are rare but possible; vascular occlusion is the most critical risk and underscores the importance of choosing an experienced, medically qualified injector.

Can the same filler used for nasolabial folds be used in other areas?

Many filler materials are studied across multiple facial zones. For example, HA fillers have been evaluated for infraorbital hollows (PMID 42488280, PMID 42448833) and perioral wrinkles (PMID 42487104), while CaHA has been studied for labial rejuvenation (PMID 42529489). Each area has distinct anatomy and risk profiles that your provider must assess separately.

How do I choose between PLLA and HA for my nasolabial folds?

The 120-week trial (PMID 42594306) showed the two materials correct folds through different time courses, so the choice often comes down to how quickly you want visible results and how you feel about gradual versus immediate correction. A board-certified dermatologist or plastic surgeon can assess your fold depth, skin quality, and goals to recommend the better fit.

Is this article medical advice?

No. This guide presents general health information drawn from peer-reviewed research and is not a substitute for individualized medical advice, diagnosis, or treatment from a licensed healthcare professional. Always consult a qualified provider before undergoing any injectable procedure.

This article is for general information and is not medical advice. Aesthetic treatment results vary by individual -- consult a licensed, qualified provider before pursuing any cosmetic procedure.